期刊文献+

造血干细胞移植中HLA-Ⅱ类基因分型影响因素的探讨 被引量:1

Study of the influencial factors of HLA class Ⅱ genotyping methods in hematopoietic stem cell transplantation
暂未订购
导出
摘要 目的:为了准确地进行造血干细胞移植供-受体的HLA-Ⅱ类配型,对HLA-Ⅱ类基因分型实验的影响因素进行了探讨。方法:采用美国莱姆达公司提供的微量SSP^TMHLA-Ⅱ类PCR-SSP分型试剂盒对400例造血干细胞移植供-受体进行基因分型。结果:采用0.5%EDTA抗凝的血标本与肝素抗凝的血标本相比,前者的护增效果好。DNA终浓度为25~200ng/ul,最佳浓度为100ng/ul。 Objective: In order to type HLA class Ⅱ of hematopoietic stem cell transplantation donor-recipient pairs accurately, the authors studied the factors impacting on HLA class Ⅱ genotyping methods. Methods: Genotyping methods of HLA-Ⅱ PCR-SSP (Lambda, Inc)were employed to genotype 400 cases of related hematopoietic stem cell transplant donors and recipients. Results: The results indicated that amplified results were much better in 0. 5% EDTA anticoagulated peripheral bled compared with heparin samples. Final DNA concentration should be 25 ~ 200 ng/μl(100ng/μl is optimal) with A260/A280 ratio between 1 .65 ~ 1.80. PCR reaction parameters is also very important in HLA class Ⅱ genotyping. The usage and the activity of Taq DNA polymerase directly affect typing results. DMIX tube should be stored at -65℃, and avoid frequently freezing and melting, otherwise, it might decrease the output of amplification. Conclusion: The proper processing of specimen and optimization d reaction conditions for HLA class Ⅱ genotyping are the key factors for good results.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2000年第7期369-370,共2页 Chinese Journal of Immunology
基金 国家自然科学基金!3990187
关键词 HLA-Ⅱ类 基因分型 造血干细胞移植 HLA class Ⅱ Genotyping Hematopoietic stem cell transplantation
  • 相关文献

参考文献1

同被引文献12

  • 1Noreen HJ, Yu N, Setterholm M, et al. Validation of DNA-based HLA-A and HLA-B testing of volunteers for a bone marrow registry through parallel testing with serology. Tissue Antigens, 2001, 57:221-229.
  • 2Hurley CK, Maiers M, Ng J, et al. Large-scale DNA-based typing of HLA-A and HLA-B at low resolution is highly accurate specific and reliable. Tis Anti, 2000, 55:352-358.
  • 3Hansen JA,Petersdorf EW,Martin PJ, et al. Impact of HLA matching on hematopoietic cell transplants from unrelated donors. Vox Sang, 2000, 78:269-271.
  • 4Petersdorf EW, Kollman C, Hurley CK, et al. Effect of HLA class Ⅱ gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience. Blood, 2001, 98:2922-2929.
  • 5Petersdorf EW, Hansen JA, Martin PJ, et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med, 2001, 345:1794-1800.
  • 6Erlich HA, Opelz G, Hansen J. HLA DNA typing and transplantation. Immunity, 2001,14:347-356.
  • 7Rubinstein P. HLA matching for bone marrow transplantation: how much is enough? N Engl J Med, 2001,345:1842-1844.
  • 8Marsh SG, Bodmer JG, Albert ED,et al. Nomenclature for factors of HLA system,2000. Hum Immunol, 2001, 62:419-468.
  • 9Hurley CK, Wade JA, Oudshoorn M, et al. A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association. Hum Immunol, 1999, 60:347-360.
  • 10Schreuder GM, Hurley CK, Marsh SG, et al. The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens, 2001, 58:109-140.

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部